Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: A nationwide follow-up study

Diabetologia

Volumn 51, Issue 4, 2008, Pages 567-574

  Horsdal, H T ^a,b   Johnsen, S P ^a,c   Sondergaard F ^a   Rungby, J ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Glucose lowering treatment; Heart failure; Hospitalisation; MI; Mortality; Myocardial infarction; Prognosis; Readmission; Type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; GLITAZONE DERIVATIVE; INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; COMORBIDITY; DENMARK; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEART FAILURE; HEART INFARCTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SOCIAL STATUS;

ADULT; AGED; AGED, 80 AND OVER; DENMARK; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 41149094943     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0947-6     Document Type: Article

References (29)

1. Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005-2012
2. Malmberg K, Yusuf S, Gerstein HC et al (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102:1014-1019
3. Meinert CL, Knatterud GL, Prout TE, Klimt CR (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 19(Suppl):789-830
4. Davis TM, Parsons RW, Broadhurst RJ, Hobbs MS, Jamrozik K (1998) Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment. Diabetes Care 21:637-640
5. Inzucchi SE, Masoudi FA, Wang Y et al (2005) Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care 28:1680-1689
6. Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA (2003) Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Exp Clin Endocrinol Diabetes 111:344-350
7. Johnsen SP, Monster TB, Olsen ML et al (2006) Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs. Am J Ther 13:134-140
8. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33:119-124
9. Gustafsson I, Hildebrandt P, Seibaek M et al (2000) Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J 21:1937-1943
10. Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M (1999) Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology 91:195-202
11. Halkin A, Roth A, Jonas M, Behar S (2001) Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction. J Thromb Thrombolysis 12:177-184
12. McGuire DK, Newby LK, Bhapkar MV et al (2004) Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 147:246-252
13. Murcia AM, Hennekens CH, Lamas GA et al (2004) Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 164:2273-2279
14. Fisman EZ, Tenenbaum A, Boyko V et al (2001) Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clin Cardiol 24:151-158
15. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398-2399
16. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB (2006) The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53:441-449
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263-268
18. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612
19. Statistics Denmark (1991) IDA-an integrated database for labour market research. Statistics Denmark, Copenhagen
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
21. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA (2006) Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48:2192-2194
22. Madsen M, Balling H, Eriksen LS (1990) The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry. Ugeskr Laeger 152:308-314 (article in Danish)
23. Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S (1996) Analyses of data quality in registries concerning diabetes mellitus-a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 20:1-10
24. Lachin JM, Christophi CA, Edelstein SL et al (2007) Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56:1153-1159
25. Kronborg J, Johnsen SH, Njolstad I, Toft I, Eriksen BO, Jenssen T (2007) Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromso Study. Diabetologia 50:1607-1614
26. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865
27. Kao J, Tobis J, McClelland RL et al (2004) Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention. Am J Cardiol 93:1347-1350
28. McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM (2007) Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 16:711-725
29. Sauer WH, Cappola AR, Berlin JA, Kimmel SE (2006) Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 97:651-654